Trial intelligence / Profile preview

Duplex-guided catheter-based foam sclerotherapy with tumescent solution for great saphenous vein varicose veins

2009-017472-25Phase 4Active

Sponsor
Universitätsklinikum Schleswig-Holstein
Start
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of 10XB101 and sodium chloride in Varicose Veins and venous stasis, sponsored by Universitätsklinikum Schleswig-Holstein. Primary endpoint: Complete occlusion of the great saphenous vein. Started Jan 2010; status: active.

02

Drugs

10XB101sodium chloride
03

Conditions

Varicose Veinsvenous stasis

Beyond the preview

Go deeper on 2009-017472-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017472-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call